Michael Kelliher
Förmögenhet: 2 M $ per 2026-06-30
Förmögenhet: 2 M $ per 2026-06-30
Michael Kelliher currently works at Capricor Therapeutics, Inc., as Independent Director from 2023 and Ardelyx, Inc., as Chief Business Officer from 2025.
Mr. Kelliher also formerly worked at Horizon Therapeutics Ltd. (Ireland), as Group Vice President-Merger & Acquisition.
Mr. Kelliher received his undergraduate degree from University College Cork.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ARDELYX, INC. 0,14 % | 2026-05-21 | 357 418 ( 0,14 % ) | 2 M $ | 2026-06-30 |
| 2026-02-28 | 0 ( -.--% ) | - $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2023-09-01 |
| ARDELYX, INC. | Företagsledare/Principal | 2024-03-25 |
| Företag | Position | Slut |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Horizon Therapeutics Ltd. (Ireland)
Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
University College Cork
University College Cork Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
Ardelyx, Inc.
Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån